SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-256035
Filing Date
2017-08-11
Accepted
2017-08-11 16:47:02
Documents
70
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d361591d10q.htm 10-Q 681950
2 EX-10.1 d361591dex101.htm EX-10.1 83157
3 EX-31.1 d361591dex311.htm EX-31.1 6846
4 EX-31.2 d361591dex312.htm EX-31.2 6861
5 EX-32.1 d361591dex321.htm EX-32.1 4531
  Complete submission text file 0001193125-17-256035.txt   5107607

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mgen-20170630.xml EX-101.INS 847209
7 XBRL TAXONOMY EXTENSION SCHEMA mgen-20170630.xsd EX-101.SCH 50673
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgen-20170630_cal.xml EX-101.CAL 67021
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgen-20170630_def.xml EX-101.DEF 270999
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgen-20170630_lab.xml EX-101.LAB 645224
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgen-20170630_pre.xml EX-101.PRE 390013
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 171025731
SIC: 8071 Services-Medical Laboratories